In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
New product reviews from March 2011.

Pharmaceutical Technology
Volume 35, Issue 3, pp. 24

Sealed pressure logger boosts process control


DataTrace MPRF pressure logger Mesa Laboratories www.mesalabs.com
Mesa Laboratories has added a pressure logger to its DataTrace MPRF line of wireless process-validation systems. The stand-alone device communicates by radio with a host interface attached to a personal computer, and users can analyze the data as it is received. The unit can help pharmaceutical manufacturers validate various chamber-pressure specifications in real time. The MPRF pressure logger also enables personnel to make real-time pressure measurements, thus enhancing process flexibility and control. The DataTrace MPRF radio-transmitting loggers are completely sealed.

Control of chromatography systems facilitates data integration


GC-2010 Plus instrument Shimadzu www.shimadzu.com
Shimadzu has enabled its GC-2010 Plus and GC-2014 gas-chromatography systems to be controlled with Waters's Empower 2 software. This modification permits clients to integrate data from various chromatographs into one networked solution. Controlling chromatography systems through the data system also provides full documentation of instrument parameters.

The Empower 2 software is designed to adapt to users' environments. For example, the product lets scientists create custom fields to record information specific to their analyses. Users also can develop custom calculations to avoid the need to transfer numbers to additional applications. The software allows users to format reports according to the needs of their laboratories.

New Product Announcements may be sent to New Products Editor, Pharmaceutical Technology, 485 Route One South, Building F, First Floor, Iselin, NJ 08830, fax 732.596.0005,
.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here